Home
>
National Drug Code (NDC)
>
Maxipime
Maxipime - 0409-0221-01 - (CEFEPIME HYDROCHLORIDE)
Drug Information of Maxipime
| Product NDC: | 0409-0221 |
| Proprietary Name: | Maxipime |
| Non Proprietary Name: | CEFEPIME HYDROCHLORIDE |
| Active Ingredient(s): | 500 mg/1 & nbsp; CEFEPIME HYDROCHLORIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Maxipime
| Product NDC: | 0409-0221 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050679 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121227 |
Package Information of Maxipime
| Package NDC: | 0409-0221-01 |
| Package Description: | 10 VIAL in 1 CARTON (0409-0221-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Information of Maxipime
| NDC Code | 0409-0221-01 |
| Proprietary Name | Maxipime |
| Package Description | 10 VIAL in 1 CARTON (0409-0221-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 0409-0221 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CEFEPIME HYDROCHLORIDE |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20121227 |
| Marketing Category Name | NDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | CEFEPIME HYDROCHLORIDE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |
